Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : BioNTech Makes European Medicines Agency Submission of Data Focusing COVID-19 Vaccine in Younger Children

10/15/2021 | 10:55am EST


© MT Newswires 2021
All news about PFIZER, INC.
10:01aPfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss P..
BU
08:32aAfrica needs to make own vaccines but hurdles are high, experts say
RE
08:11aSpain approves COVID vaccinations for children 5 to 11
RE
07:45aMarketScreener's World Press Review - December 7, 2021
07:43aCORONAVIRUS - GABON : The United States donates more than 100,000 new doses of Pfizer vacc..
AQ
07:18aCORONAVIRUS - GABON : The United States donates more than 100,000 new doses of Pfizer vacc..
AQ
07:16aEU agencies endorse mix-and-match of COVID-19 vaccines
RE
05:34aNew York City to Impose Vaccine Mandate on Private Sector Companies
MT
04:23aEU travel curbs needed till more known about Omicron -Germany's Spahn
RE
01:16aPfizer And BioNTech To Request Approval For Vaccine Use In 12-To-15-Year-Olds – M..
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 239 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 13,3x
Yield 2021 3,06%
Capitalization 289 B 289 B -
EV / Sales 2021 3,89x
EV / Sales 2022 3,56x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 51,48 $
Average target price 49,78 $
Spread / Average Target -3,31%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.41.65%288 950
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321
ABBVIE INC.10.92%214 532